These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12195758)

  • 1. Chemotherapy with cisplatin and 5-fluorouracil chronomodulated infusion in locally advanced or metastatic/recurrent carcinoma of the cervix.
    Miglietta L; Bruzzone M; Ghione G; Pepe A; Marenghi C; Ragni N; Boccardo F
    Tumori; 2002; 88(3):204-8. PubMed ID: 12195758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
    Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.
    Chitapanarux I; Tonusin A; Sukthomya V; Charuchinda C; Pukanhapan N; Lorvidhaya V
    Gynecol Oncol; 2003 Jun; 89(3):402-7. PubMed ID: 12798702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience.
    Aitini E; Rabbi C; Mambrini A; Cavazzini G; Pari F; Zamagni D; Cantore M; Pagani M; Sorio M; Lusenti A; Adami F; Smerieri F
    Tumori; 2001; 87(1):20-4. PubMed ID: 11669552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
    J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Lin HX; Hua YJ; Chen QY; Luo DH; Sun R; Qiu F; Mo HY; Mai HQ; Guo X; Xian LJ; Hong MH; Guo L
    Chin J Cancer; 2013 Sep; 32(9):502-11. PubMed ID: 23816561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
    Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
    Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
    Lévi FA; Zidani R; Vannetzel JM; Perpoint B; Focan C; Faggiuolo R; Chollet P; Garufi C; Itzhaki M; Dogliotti L
    J Natl Cancer Inst; 1994 Nov; 86(21):1608-17. PubMed ID: 7932825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin.
    Ducreux M; Rougier P; Fandi A; Clavero-Fabri MC; Villing AL; Fassone F; Fandi L; Zarba J; Armand JP
    Ann Oncol; 1998 Jun; 9(6):653-6. PubMed ID: 9681080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
    Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
    Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study.
    Nagai N; Oshita T; Murakami J; Shigemasa K; Hirokawa Y; Ohama K
    Oncol Rep; 2001; 8(1):119-25. PubMed ID: 11115582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
    Dimopoulos MA; Papadimitriou CA; Sarris K; Aravantinos G; Kalofonos C; Gika D; Gourgoulis GM; Efstathiou E; Skarlos D; Bafaloukos D
    Gynecol Oncol; 2002 Jun; 85(3):476-82. PubMed ID: 12051877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.
    Eralp Y; Saip P; Sakar B; Kucucuk S; Aydiner A; Dincer M; Aslay I; Topuz E
    Int J Gynecol Cancer; 2003; 13(4):497-504. PubMed ID: 12911727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
    Orecchia R; Jereczek-Fossa BA; Catalano G; Chiesa F; De Pas T; Masci G; Krengli M; Vavassori A; De Paoli F; Robertson C; Marrocco E; De Braud F
    Oncology; 2002; 63(2):115-23. PubMed ID: 12239445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.